文献速递肝病

急性失代偿肝硬化患者血浆免疫调节介质与3个月死亡率相关

Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-08-22

研究纳入接受白蛋白输注的急性失代偿肝硬化患者,比较45例存活者与27例死亡者血浆炎症介质谱,发现住院时前列腺素E2水平高且随白蛋白输注下降,第5天血浆IL4升高与3个月存活相关。

要点

  • 存活者与死亡者血浆炎症谱不同,死亡者白细胞计数、C反应蛋白及肾功能障碍更高。
  • 住院时前列腺素E2水平高,随白蛋白输注下降。
  • 第5天血浆IL4升高与3个月存活相关,中和IL4后巨噬细胞TNF分泌增至死亡者血浆水平。

核心结论

  • 急性失代偿肝硬化接受白蛋白治疗患者中,血浆炎症标志物谱与3个月死亡率相关。
  • 住院最初几天前列腺素E2升高可能促进炎症,第5天血浆IL4升高与存活增加相关。

研究设计与样本

  • 研究数据来自白蛋白预防慢性肝衰竭感染可行性研究,英国10家医院急性失代偿肝硬化患者接受白蛋白输注。
  • 收集第1、5、10、15天血浆样本,分析45例存活者与27例死亡者,每次分析纳入4至14例患者样本。
  • 将健康人单核细胞来源巨噬细胞与患者血浆孵育,脂多糖刺激后测TNF及可溶性炎症介质分泌。

主要发现

  • 存活者与死亡者血浆炎症谱不同。
  • 患者住院时前列腺素E2水平高,随白蛋白输注下降。
  • 治疗第5天血浆IL4升高与3个月存活相关。
  • 存活者第5天血浆经IL4中和抗体预处理后孵育巨噬细胞,TNF产生显著增加至死亡者血浆水平。
  • 死亡者基线特征相似但白细胞计数、C反应蛋白水平及肾功能障碍更高。

临床怎么用

  • 血浆炎症介质谱(前列腺素E2、IL4)可能用于识别急性失代偿肝硬化白蛋白治疗患者的死亡风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Infection is a common cause of death in patients with cirrhosis. We investigated the association between the innate immune response and death within 3 months of hospitalization. METHODS: Plasma samples were collected on days 1, 5, 10, and 15 from participants recruited into the albumin to prevent infection in chronic liver failure feasibility study. Patients with acute decompensated cirrhosis were given albumin infusions at 10 hospitals in the United Kingdom. Data were obtained from 45 survivors and 27 non-survivors. We incubated monocyte-derived macrophages from healthy individuals with patients' plasma samples and measured activation following lipopolysaccharide administration, determined by secretion of tumor necrosis factor and soluble mediators of inflammation. Each analysis included samples from 4 to 14 patients. RESULTS: Plasma samples from survivors vs non-survivors had different inflammatory profiles. Levels of prostaglandin E2 were high at times of patient hospitalization and decreased with albumin infusions. Increased levels of interleukin 4 (IL4) in plasma collected at day 5 of treatment were associated with survival at 3 months. Incubation of monocyte-derived macrophages with day 5 plasma from survivors, pre-incubated with a neutralizing antibody against IL4, caused a significant increase in tumor necrosis factor production to the level of non-survivor plasma. Although baseline characteristics were similar, non-survivors had higher white cell counts and levels of C-reactive protein and renal dysfunction. CONCLUSIONS: We identified profiles of inflammatory markers in plasma that are associated with 3-month mortality in patients with acute decompensated cirrhosis given albumin. Increases in prostaglandin E2 might promote inflammation within the first few days after hospitalization, and increased levels of plasma IL4 at day 5 are associated with increased survival. Clinicaltrialsregister.eu: EudraCT 2014-002300-24.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Becares N, Härmälä S, China L, et al. Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality. Clin Gastroenterol Hepatol. 2019. PMID: 31446184. doi:10.1016/j.cgh.2019.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。